Literature DB >> 7607734

Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

V L Burt1, J A Cutler, M Higgins, M J Horan, D Labarthe, P Whelton, C Brown, E J Roccella.   

Abstract

The objective of this study was to describe secular trends in the distribution of blood pressure and prevalence of hypertension in US adults and changes in rates of awareness, treatment, and control of hypertension. The study design comprised nationally representative cross-sectional surveys with both an in-person interview and a medical examination that included blood pressure measurement. Between 6530 and 13,645 adults, aged 18 through 74 years, were examined in each of four separate national surveys during 1960-1962, 1971-1974, 1976-1980, and 1988-1991. Protocols for blood pressure measurement varied significantly across the surveys and are presented in detail. Between the first (1971-1974) and second (1976-1980) National Health and Nutrition Examination Surveys (NHANES I and NHANES II, respectively), age-adjusted prevalence of hypertension at > or = 160/95 mm Hg remained stable at approximately 20%. In NHANES III (1988-1991), it was 14.2%. Age-adjusted prevalence at > or = 140/90 mm Hg peaked at 36.3% in NHANES I and declined to 20.4% in NHANES III. Age-specific prevalence rates have decreased for every age-sex-race subgroup except for black men aged 50 and older. Age-adjusted mean systolic pressures declined progressively from 131 mm Hg at the NHANES I examination to 119 mm Hg at the NHANES III examination. The mean systolic and diastolic pressures of every sex-race subgroup declined between NHANES II and III (3 to 6 mm Hg systolic, 6 to 9 mm Hg diastolic). During the interval between NHANES II and III, the threshold for defining hypertension was changed from 160/95 to 140/90 mm Hg.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607734     DOI: 10.1161/01.hyp.26.1.60

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  211 in total

1.  The challenge of obesity-related chronic diseases.

Authors:  J M Clark; F L Brancati
Journal:  J Gen Intern Med       Date:  2000-11       Impact factor: 5.128

2.  Health status of the Pakistani population: a health profile and comparison with the United States.

Authors:  G Pappas; T Akhtar; P J Gergen; W C Hadden; A Q Khan
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 3.  Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

Authors:  R S Chen; P Lapuerta
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

4.  Hypertensive therapy: attacking the renin-angiotensin system.

Authors:  T Bishop; V M Figueredo
Journal:  West J Med       Date:  2001-08

5.  The reduction in disability among the elderly.

Authors:  D M Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

6.  Racial and ethnic disparities in indicators of physical health status: do they still exist throughout late life?

Authors:  Kristin J August; Dara H Sorkin
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

7.  Child health in the United States: recent trends in racial/ethnic disparities.

Authors:  Neil K Mehta; Hedwig Lee; Kelly R Ylitalo
Journal:  Soc Sci Med       Date:  2012-09-17       Impact factor: 4.634

Review 8.  Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?

Authors:  Christopher A Newton; Philip Raskin
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 9.  The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.

Authors:  Yogini Ratnasabapathy; Carlene M M Lawes; Craig S Anderson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Combination drug treatment of hypertension: have we come full circle?

Authors:  Addison A Taylor
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.